Back to search

Article

TERT Promoter Mutations Combined with TP53 Mutations as Potential Biomarkers for Hepatocellular Carcinoma Recurrence and Prognosis

2024-09-18

Abstract excerpt

<title>Abstract</title> <p>Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, and ranks among the most lethal malignancies globally, primarily due to its high rates of recurrence and metastasis. Despite the urgency, no reliable biomarkers currently exist for predicting tumor recurrence in HCC. Telomerase reverse transcriptase (<italic>TERT</italic>) promoter mutations (<italic>TERTpm</ital...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e4c2b1af-067a-5237-93db-1a837a86d83e
DOI
10.21203/rs.3.rs-4767398/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TERT Promoter Mutations Combined with TP53 Mutations as Potential Biomarkers for Hepatocellular Carcinoma Recurrence and PrognosisDOI 10.21203/rs.3.rs-4767398/v1
Select a neighboring publication to make it the new centre.